[Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma].

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Wiadomosci lekarskie

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 17966882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Arginase: An emerging and promising therapeutic target for cancer treatment.

  2022cites this paper
• Prognostic Implications of Arginase and Cytokeratin 19 Expression in Hepatocellular Carcinoma After Curative Hepatectomy: Correlation With Recurrence-Free Survival

  2019cites this paper
• A study of serum arginase activity in diagnosis of liver diseases

  2019cites this paper
• Serum levels of Arginase Isoenzyme Activity, Alpha- Fetoprotein-L3 and Endostatin as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients

  2016cites this paper
• Interação da proteina e2 do vírus da hepatite c com o receptor de ldl e cd81 presentes em células endoteliais e ativação da resposta inflamatória

  2012cites this paper
• Hepatitis C virus targets over‐expression of arginase I in hepatocarcinogenesis

  2009cites this paper